TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Web-based Computer-tailored Intervention on Workplace Sitting: a Randomized Controlled Trial
Brief Summary: A theory-driven, web-based, computer-tailored advice to influence sitting at work was developed. The study investigated the effects of this computer-tailored intervention to influence workplace sitting on behavioural measures.


Options:
A: Arm Label: tailored group; Type: EXPERIMENTAL; Interventions: Behavioral: Start to stand | Arm Label: generic group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: generic advice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Start to stand; Assigned to Arm(s): tailored group | Intervention Type: BEHAVIORAL; Name: generic advice; Assigned to Arm(s): generic group
B: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
C: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group
D: Arm Label: High intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Low intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): High intensity intervention group, Low intensity intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Web-based Computer-tailored Intervention on Workplace Sitting: a Randomized Controlled Trial
Brief Summary: A theory-driven, web-based, computer-tailored advice to influence sitting at work was developed. The study investigated the effects of this computer-tailored intervention to influence workplace sitting on behavioural measures.


Options:
A: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
B: Arm Label: tailored group; Type: EXPERIMENTAL; Interventions: Behavioral: Start to stand | Arm Label: generic group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: generic advice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Start to stand; Assigned to Arm(s): tailored group | Intervention Type: BEHAVIORAL; Name: generic advice; Assigned to Arm(s): generic group
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Walkadoo | Intervention Type: BEHAVIORAL; Name: Walkadoo; Assigned to Arm(s): Intervention
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention group | Arm Label: Intervention control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control group | Intervention Type: BEHAVIORAL; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Control group; Assigned to Arm(s): Intervention control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Systemic Inflammatory Response Evaluation With the Use of Inhaled Anesthetic Sevoflurane During CPB
Brief Summary: Cardiac surgery has evolved considerably after the advent of cardiopulmonary bypass (CPB), a feature that allowed more precision and tranquility to the heart surgeon. But their influence on exacerbation of inflammatory response can unbalance the whole homeostasis so happens surgical trauma. The attenuation of the systemic inflammatory response in major surgeries like cardiac surgery for aortic aneurysm appears to represent an important advance in reducing morbidity and mortality of these patients. Some studies suggest that inhaled anesthetics such as sevoflurane appear to play an important role in this control, but the mechanism by which this happens is still unclear. This study has the primary purpose of analyzing from a clinical study sevoflurane inhalation anesthetic can change the inflammatory response induced by CPB, significantly reducing the release of inflammatory markers, especially elastase PMN.


Options:
A: Arm Label: Methylprednisolone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylprednisolone | Arm Label: Placebo (NaCl); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Methylprednisolone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo (NaCl)
B: Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: Rosuvastatin | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Sugar pill
C: Arm Label: Sevoflurane Group; Type: N/A; Interventions: Drug: Sevoflurane | Arm Label: Not Sevoflurane Group; Type: N/A; Interventions: N/A | Intervention Type: DRUG; Name: Sevoflurane; Assigned to Arm(s): Sevoflurane Group
D: Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone, Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Growing Resilience: an RCT on the Health Impact of Gardens With Wind River Indian Reservation
Brief Summary: The Growing Resilience research leverages reservation-based assets of land, family, culture, and front-line tribal health organizations to develop and evaluate home food gardens as a family-based health promotion intervention to reduce disparities suffered by Native Americans in nearly every measure of health. Home gardening interventions show great promise for enabling families to improve their health, and this study aims to fulfill that promise with university and Wind River Indian Reservation partners. The investigators will develop an empowering, scalable, and sustainable family-based health promotion intervention with, by, and for Native American families and conduct the first RCT to assess the health impacts of home gardens.


Options:
A: Arm Label: ACTION PAC Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ACTION PAC, Behavioral: Communication with parents | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication with parents | Intervention Type: BEHAVIORAL; Name: ACTION PAC; Assigned to Arm(s): ACTION PAC Behavioral Intervention | Intervention Type: BEHAVIORAL; Name: Communication with parents; Assigned to Arm(s): ACTION PAC Behavioral Intervention, Comparison
B: Arm Label: Gardening; Type: EXPERIMENTAL; Interventions: Other: Garden | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Garden; Assigned to Arm(s): Gardening
C: Intervention Type: BEHAVIORAL; Name: FLOW; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: SelfHelp; Assigned to Arm(s): N/A
D: Arm Label: Mentoring to be Active; Type: EXPERIMENTAL; Interventions: Behavioral: Mentoring to be Active with Accelerometers | Arm Label: Planning to be Active; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Planning to be Active with Accelerometers | Arm Label: Peer Mentors; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: High School Teachers; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mentoring to be Active with Accelerometers; Assigned to Arm(s): Mentoring to be Active | Intervention Type: BEHAVIORAL; Name: Planning to be Active with Accelerometers; Assigned to Arm(s): Planning to be Active

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BI 655066 / ABBV-066 (Risankizumab) Versus Placebo In a Multicenter Randomized Double-blind Study in Patients With Moderate to Severe Chronic Plaque Psoriasis Evaluating the Efficacy and Safety With Randomized Withdrawal and Re-treatment (IMMhance)
Brief Summary: This was a multinational, multicenter, randomized, double-blind, placebo controlled study with randomized withdrawal and retreatment, evaluating the safety and efficacy of risankizumab 150 mg subcutaneous (SC) in participants with moderate to severe chronic plaque psoriasis.


Options:
A: Arm Label: ustekinumab 45 mg; Type: EXPERIMENTAL; Interventions: Drug: ustekinumab | Arm Label: ustekinumab 90 mg; Type: EXPERIMENTAL; Interventions: Drug: ustekinumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: ustekinumab; Assigned to Arm(s): ustekinumab 45 mg, ustekinumab 90 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: Risankizumab; Type: EXPERIMENTAL; Interventions: Drug: Risankizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risankizumab; Assigned to Arm(s): Risankizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo for rizankizumab | Arm Label: Risankizumab; Type: EXPERIMENTAL; Interventions: Drug: risankizumab | Intervention Type: DRUG; Name: risankizumab; Assigned to Arm(s): Risankizumab | Intervention Type: DRUG; Name: placebo for rizankizumab; Assigned to Arm(s): Placebo
D: Arm Label: Immediate Methotrexate Cessation; Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab | Arm Label: Gradual Reduction of Methotrexate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ustekinumab, Drug: Methotrexate | Intervention Type: DRUG; Name: Ustekinumab; Assigned to Arm(s): Gradual Reduction of Methotrexate, Immediate Methotrexate Cessation | Intervention Type: DRUG; Name: Methotrexate; Assigned to Arm(s): Gradual Reduction of Methotrexate

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BI 655066 / ABBV-066 (Risankizumab) Versus Placebo In a Multicenter Randomized Double-blind Study in Patients With Moderate to Severe Chronic Plaque Psoriasis Evaluating the Efficacy and Safety With Randomized Withdrawal and Re-treatment (IMMhance)
Brief Summary: This was a multinational, multicenter, randomized, double-blind, placebo controlled study with randomized withdrawal and retreatment, evaluating the safety and efficacy of risankizumab 150 mg subcutaneous (SC) in participants with moderate to severe chronic plaque psoriasis.


Options:
A: Arm Label: Risankizumab; Type: EXPERIMENTAL; Interventions: Drug: Risankizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risankizumab; Assigned to Arm(s): Risankizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Apremilast; Type: EXPERIMENTAL; Interventions: Drug: Apremilast, Drug: Placebo, Drug: Placebo-Apremilast | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Placebo-Apremilast | Intervention Type: DRUG; Name: Apremilast; Assigned to Arm(s): Apremilast | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Apremilast, Placebo | Intervention Type: DRUG; Name: Placebo-Apremilast; Assigned to Arm(s): Apremilast, Placebo
C: Arm Label: Risankizumab; Type: EXPERIMENTAL; Interventions: Drug: Risankizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo solution for risankizumab | Intervention Type: DRUG; Name: Risankizumab; Assigned to Arm(s): Risankizumab | Intervention Type: DRUG; Name: Placebo solution for risankizumab; Assigned to Arm(s): Placebo
D: Arm Label: Apremilast 30 mg BID; Type: EXPERIMENTAL; Interventions: Drug: Apremilast, Other: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Apremilast; Assigned to Arm(s): Apremilast 30 mg BID | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Apremilast 30 mg BID, Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy
Brief Summary: InterFast is a Cohort study with an embedded randomized controlled pilot trial. Study participants will be healthy subjects and subjects who already practice Alternate Day Fasting. The trial will include 100 participants (50 Participants in Alternate Day Fasting group and 50 participants in the control group). Those participants in the control group will be asked to participate in a short randomized controlled trial, where they will be either allocated to an Alternative Day Fasting group or another control visit.


Options:
A: Arm Label: Caloric restriction only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Caloric restriction only | Arm Label: Caloric restriction plus TRF morning; Type: EXPERIMENTAL; Interventions: Behavioral: Caloric restriction plus TRF morning | Arm Label: Caloric restriction plus TRF night; Type: EXPERIMENTAL; Interventions: Behavioral: Caloric restriction plus TRF night | Intervention Type: BEHAVIORAL; Name: Caloric restriction only; Assigned to Arm(s): Caloric restriction only | Intervention Type: BEHAVIORAL; Name: Caloric restriction plus TRF morning; Assigned to Arm(s): Caloric restriction plus TRF morning | Intervention Type: BEHAVIORAL; Name: Caloric restriction plus TRF night; Assigned to Arm(s): Caloric restriction plus TRF night
B: Arm Label: Alternate day fasting; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Alternate day fasting | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Alternate day fasting; Assigned to Arm(s): Alternate day fasting
C: Arm Label: TRF; Type: EXPERIMENTAL; Interventions: Behavioral: Time Restricted Feeding | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Time Restricted Feeding; Assigned to Arm(s): TRF | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Control group; Type: OTHER; Interventions: Other: control group | Arm Label: Intermittent Fasting group; Type: EXPERIMENTAL; Interventions: Other: Intermittent Fasting group | Intervention Type: OTHER; Name: Intermittent Fasting group; Assigned to Arm(s): Intermittent Fasting group | Intervention Type: OTHER; Name: control group; Assigned to Arm(s): Control group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial
Brief Summary: The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. Depending on the treatment study arm either verum- or Sham sham-acupuncture will be applied. Acupuncture is applied treatment bi-weekly during the first week of radiotherapy, thereafter weekly until the end of radiotherapy; the follow-up visits include clinical workup as well as questionnaires.


Options:
A: Arm Label: octreotide + radiation; Type: EXPERIMENTAL; Interventions: Drug: octreotide acetate, Radiation: radiation | Arm Label: placebo + radiation; Type: ACTIVE_COMPARATOR; Interventions: Other: placebo, Radiation: radiation | Intervention Type: DRUG; Name: octreotide acetate; Assigned to Arm(s): octreotide + radiation | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo + radiation | Intervention Type: RADIATION; Name: radiation; Assigned to Arm(s): octreotide + radiation, placebo + radiation
B: Arm Label: protons; Type: EXPERIMENTAL; Interventions: Procedure: radiation | Arm Label: carbon ions; Type: EXPERIMENTAL; Interventions: Procedure: radiation | Intervention Type: PROCEDURE; Name: radiation; Assigned to Arm(s): carbon ions, protons
C: Arm Label: Arm Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Arm Soy Supplement; Type: EXPERIMENTAL; Interventions: Drug: Soy Supplement | Intervention Type: DRUG; Name: Soy Supplement; Assigned to Arm(s): Arm Soy Supplement | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm Placebo
D: Arm Label: Group A: Verum Acupuncture; Type: EXPERIMENTAL; Interventions: Radiation: Radiotherapy, Device: Needle Acupuncture | Arm Label: Group B: Sham Acupuncture; Type: SHAM_COMPARATOR; Interventions: Radiation: Radiotherapy, Device: Needle Acupuncture | Intervention Type: RADIATION; Name: Radiotherapy; Assigned to Arm(s): Group A: Verum Acupuncture, Group B: Sham Acupuncture | Intervention Type: DEVICE; Name: Needle Acupuncture; Assigned to Arm(s): Group A: Verum Acupuncture, Group B: Sham Acupuncture

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
Brief Summary: To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement.


Options:
A: Arm Label: Surgical aortic valve replacement (SAVR); Type: ACTIVE_COMPARATOR; Interventions: Procedure: SAVR | Arm Label: Transcatheter aortic valve replacement (TAVR); Type: EXPERIMENTAL; Interventions: Device: SAPIEN 3 THV | Intervention Type: PROCEDURE; Name: SAVR; Assigned to Arm(s): Surgical aortic valve replacement (SAVR) | Intervention Type: DEVICE; Name: SAPIEN 3 THV; Assigned to Arm(s): Transcatheter aortic valve replacement (TAVR)
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: CA-TAVR, Device: Amplatzer Duct Occluder | Intervention Type: PROCEDURE; Name: CA-TAVR; Assigned to Arm(s): A | Intervention Type: DEVICE; Name: Amplatzer Duct Occluder; Assigned to Arm(s): A
C: Arm Label: Medtronic CoreValve® System TAVI; Type: EXPERIMENTAL; Interventions: Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI), Device: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI) | Arm Label: SAVR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical Aortic Valve Replacement (SAVR) | Intervention Type: DEVICE; Name: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Assigned to Arm(s): Medtronic CoreValve® System TAVI | Intervention Type: PROCEDURE; Name: Surgical Aortic Valve Replacement (SAVR); Assigned to Arm(s): SAVR | Intervention Type: DEVICE; Name: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI); Assigned to Arm(s): Medtronic CoreValve® System TAVI
D: Arm Label: Medtronic Transcatheter Aortic Valve Replacement Systems; Type: EXPERIMENTAL; Interventions: Device: Medtronic Transcatheter Aortic Valve Replacement Systems | Arm Label: Surgical Aortic Valve Replacement (SAVR); Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical Aortic Valve Replacement (SAVR) | Intervention Type: DEVICE; Name: Medtronic Transcatheter Aortic Valve Replacement Systems; Assigned to Arm(s): Medtronic Transcatheter Aortic Valve Replacement Systems | Intervention Type: DEVICE; Name: Surgical Aortic Valve Replacement (SAVR); Assigned to Arm(s): Surgical Aortic Valve Replacement (SAVR)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
Brief Summary: To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement.


Options:
A: Arm Label: Cardiac Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Cardiac Rehabilitation | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cardiac Rehabilitation; Assigned to Arm(s): Cardiac Rehabilitation
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Integrated rehabilitation | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated rehabilitation; Assigned to Arm(s): Intervention group
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Threshold | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Device: sham threshold | Intervention Type: DEVICE; Name: Threshold; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: sham threshold; Assigned to Arm(s): 2
D: Arm Label: Surgical aortic valve replacement (SAVR); Type: ACTIVE_COMPARATOR; Interventions: Procedure: SAVR | Arm Label: Transcatheter aortic valve replacement (TAVR); Type: EXPERIMENTAL; Interventions: Device: SAPIEN 3 THV | Intervention Type: PROCEDURE; Name: SAVR; Assigned to Arm(s): Surgical aortic valve replacement (SAVR) | Intervention Type: DEVICE; Name: SAPIEN 3 THV; Assigned to Arm(s): Transcatheter aortic valve replacement (TAVR)

Answer: D